BioSpace News Archive

Hansa Biopharma AB, “Hansa”, (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, and Genethon, a pioneer and a leader in gene therapy research and development for rare genetic diseases, today announced they have entered a research and development collaboration.

The Insight Partners published latest research report on “Radiopharmaceuticals Market Growth Report, Size, Trends, Revenue Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Product Type, Application and End User” the global market size is projected to reach USD 13,818.17 million by 2028 from USD 7,550.74 million in 2021; it is expected to grow at a CAGR of 9% from 2021 to 2028.

Almaden Genomics has updated its g.nome platform to integrate with Jupyter Notebook, allowing bioinformaticians and data scientists to leverage the cloud-native platform’s genomic workflows in the environment and programming language they are most familiar with.

Circular Genomics, the leading company in developing circular RNA-based precision medicine tools, data and diagnostics for neurology and psychiatry, has appointed Paul Sargeant, PhD, to serve as Chief Executive Officer.

Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the first quarter ended March 31, 2023, on Thursday, May 11, 2023, after the market close.